Walleye Trading
VKTX icon

Walleye Trading’s Viking Therapeutics VKTX Stock Holding History

Walleye Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
33,938
+23,931
+239% +$773K ﹤0.01% 2102
2026
Q1 		$326K Sell
10,007
-201,897
-95% -$6.49M ﹤0.01% 2837
2025
Q4 		$7.45M Buy
211,904
+49,422
+30% +$1.75M 0.01% 1071
2025
Q3 		$4.27M Buy
162,482
+128,054
+372% +$3.82M 0.01% 1336
2025
Q2 		$912K Sell
34,428
-11,614
-25% -$306K ﹤0.01% 2263
2025
Q1 		$1.11M Buy
46,042
+16,626
+57% +$525K ﹤0.01% 1994
2024
Q4 		$1.18M Buy
29,416
+22,473
+324% +$1.28M ﹤0.01% 2043
2024
Q3 		$440K Sell
6,943
-5,609
-45% -$329K ﹤0.01% 2596
2024
Q2 		$665K Buy
12,552
+243
+2% +$15.9K ﹤0.01% 2331
2024
Q1 		$1.01M Sell
12,309
-15,544
-56% -$692K ﹤0.01% 2241
2023
Q4 		$518K Buy
+27,853
New +$364K ﹤0.01% 3041
2023
Q2 		– Sell
-161,841
Closed -$3.39M – 5242
2023
Q1 		$2.69M Buy
161,841
+96,589
+148% +$998K 0.01% 1473
2022
Q4 		$613K Buy
65,252
+32,475
+99% +$145K ﹤0.01% 2644
2022
Q3 		$89K Buy
+32,777
New +$107K ﹤0.01% 4090
2020
Q3 		– Sell
-1,669
Closed -$11.5K – 4659
2020
Q2 		$12K Buy
+1,669
New +$11.1K ﹤0.01% 4053
2019
Q1 		– Sell
-35,603
Closed -$298K – 4805
2018
Q4 		$272K Buy
35,603
+12,205
+52% +$146K ﹤0.01% 3071
2018
Q3 		$408K Sell
23,398
-12,589
-35% -$150K ﹤0.01% 3113
2018
Q2 		$342K Sell
35,987
-151,109
-81% -$1.01M ﹤0.01% 3182
2018
Q1 		$818K Buy
+187,096
New +$1.04M ﹤0.01% 2141

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Walleye Trading's VKTX Position: Q2 2026 in Review

Walleye Trading increased its Viking Therapeutics (VKTX) stake by 239% in Q2 2026, buying an estimated $773K and bringing the position to 33,938 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Walleye Trading first reported a position in VKTX in Q1 2018 and has held it in 19 quarters since. The position peaked at $7.45M in Q4 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Walleye Trading held 33,938 shares of Viking Therapeutics worth $1.32M as of Q2 2026.
  • Walleye Trading bought 23,931 Viking Therapeutics shares in Q2 2026, an estimated $773K.
  • Viking Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #2102 holding.
  • Walleye Trading first reported a position in Viking Therapeutics in Q1 2018 and has held it in 19 quarters since.
  • Walleye Trading's Viking Therapeutics position peaked at $7.45M in Q4 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.